nodes	percent_of_prediction	percent_of_DWPC	metapath
Cimetidine—SLC22A5—Dactinomycin—testicular cancer	0.0768	0.0945	CbGbCtD
Cimetidine—ABCB11—Vinblastine—testicular cancer	0.0712	0.0876	CbGbCtD
Cimetidine—CYP3A7—Ifosfamide—testicular cancer	0.0471	0.058	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0471	0.058	CbGbCtD
Cimetidine—SLC22A2—Vinblastine—testicular cancer	0.0459	0.0564	CbGbCtD
Cimetidine—ABCB11—Doxorubicin—testicular cancer	0.0438	0.0539	CbGbCtD
Cimetidine—SLC22A2—Cisplatin—testicular cancer	0.0421	0.0518	CbGbCtD
Cimetidine—SLC22A11—Methotrexate—testicular cancer	0.0403	0.0495	CbGbCtD
Cimetidine—SLC22A7—Methotrexate—testicular cancer	0.0384	0.0472	CbGbCtD
Cimetidine—CYP3A5—Ifosfamide—testicular cancer	0.0354	0.0435	CbGbCtD
Cimetidine—CYP2C8—Ifosfamide—testicular cancer	0.034	0.0418	CbGbCtD
Cimetidine—CYP2C19—Ifosfamide—testicular cancer	0.0285	0.0351	CbGbCtD
Cimetidine—CYP2C9—Ifosfamide—testicular cancer	0.0237	0.0292	CbGbCtD
Cimetidine—SLC22A8—Methotrexate—testicular cancer	0.0234	0.0288	CbGbCtD
Cimetidine—CYP2E1—Etoposide—testicular cancer	0.0218	0.0268	CbGbCtD
Cimetidine—ABCB1—Dactinomycin—testicular cancer	0.0195	0.024	CbGbCtD
Cimetidine—CYP3A5—Etoposide—testicular cancer	0.0169	0.0208	CbGbCtD
Cimetidine—SLC22A6—Methotrexate—testicular cancer	0.0163	0.0201	CbGbCtD
Cimetidine—CYP2C8—Etoposide—testicular cancer	0.0163	0.02	CbGbCtD
Cimetidine—CYP3A4—Ifosfamide—testicular cancer	0.0138	0.017	CbGbCtD
Cimetidine—CYP1A2—Etoposide—testicular cancer	0.0126	0.0155	CbGbCtD
Cimetidine—ABCB1—Vinblastine—testicular cancer	0.0122	0.015	CbGbCtD
Cimetidine—CYP2C9—Cisplatin—testicular cancer	0.0115	0.0142	CbGbCtD
Cimetidine—CYP2D6—Vinblastine—testicular cancer	0.0115	0.0142	CbGbCtD
Cimetidine—ABCB1—Cisplatin—testicular cancer	0.0112	0.0138	CbGbCtD
Cimetidine—ABCB1—Etoposide—testicular cancer	0.011	0.0135	CbGbCtD
Cimetidine—ABCB1—Doxorubicin—testicular cancer	0.0075	0.00923	CbGbCtD
Cimetidine—CYP3A4—Vinblastine—testicular cancer	0.00732	0.009	CbGbCtD
Cimetidine—ABCB1—Methotrexate—testicular cancer	0.00727	0.00894	CbGbCtD
Cimetidine—CYP2D6—Doxorubicin—testicular cancer	0.00707	0.0087	CbGbCtD
Cimetidine—CYP3A4—Etoposide—testicular cancer	0.00659	0.00811	CbGbCtD
Cimetidine—CYP3A4—Doxorubicin—testicular cancer	0.0045	0.00553	CbGbCtD
Cimetidine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00123	0.0804	CbGpPWpGaD
Cimetidine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000849	0.0557	CbGpPWpGaD
Cimetidine—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000757	0.0496	CbGpPWpGaD
Cimetidine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000687	0.045	CbGpPWpGaD
Cimetidine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00064	0.042	CbGpPWpGaD
Cimetidine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000638	0.0419	CbGpPWpGaD
Cimetidine—SLC47A1—seminal vesicle—testicular cancer	0.000601	0.0588	CbGeAlD
Cimetidine—FMO1—female gonad—testicular cancer	0.000594	0.0581	CbGeAlD
Cimetidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000577	0.0379	CbGpPWpGaD
Cimetidine—SLC47A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000557	0.0365	CbGpPWpGaD
Cimetidine—Thrombocytopenia—Vinblastine—testicular cancer	0.000555	0.00343	CcSEcCtD
Cimetidine—Erythema multiforme—Ifosfamide—testicular cancer	0.000544	0.00336	CcSEcCtD
Cimetidine—Renal failure—Cisplatin—testicular cancer	0.000543	0.00336	CcSEcCtD
Cimetidine—Pancytopenia—Etoposide—testicular cancer	0.000539	0.00333	CcSEcCtD
Cimetidine—Fatigue—Chlorambucil—testicular cancer	0.000533	0.00329	CcSEcCtD
Cimetidine—Neutropenia—Etoposide—testicular cancer	0.000531	0.00328	CcSEcCtD
Cimetidine—Malaise—Bleomycin—testicular cancer	0.000529	0.00327	CcSEcCtD
Cimetidine—SLC22A4—seminal vesicle—testicular cancer	0.000527	0.0515	CbGeAlD
Cimetidine—Leukopenia—Bleomycin—testicular cancer	0.000525	0.00324	CcSEcCtD
Cimetidine—Atrioventricular block—Epirubicin—testicular cancer	0.000523	0.00323	CcSEcCtD
Cimetidine—Musculoskeletal pain—Epirubicin—testicular cancer	0.000514	0.00317	CcSEcCtD
Cimetidine—SLC22A3—embryo—testicular cancer	0.00051	0.0499	CbGeAlD
Cimetidine—Feeling abnormal—Chlorambucil—testicular cancer	0.000509	0.00315	CcSEcCtD
Cimetidine—Pneumonia—Etoposide—testicular cancer	0.000509	0.00315	CcSEcCtD
Cimetidine—Aplastic anaemia—Methotrexate—testicular cancer	0.000509	0.00315	CcSEcCtD
Cimetidine—Alopecia—Ifosfamide—testicular cancer	0.000509	0.00314	CcSEcCtD
Cimetidine—Bradycardia—Cisplatin—testicular cancer	0.000505	0.00312	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.000502	0.0031	CcSEcCtD
Cimetidine—Myalgia—Bleomycin—testicular cancer	0.000499	0.00309	CcSEcCtD
Cimetidine—Renal failure—Etoposide—testicular cancer	0.000498	0.00308	CcSEcCtD
Cimetidine—Malaise—Dactinomycin—testicular cancer	0.000493	0.00305	CcSEcCtD
Cimetidine—Leukopenia—Dactinomycin—testicular cancer	0.000489	0.00303	CcSEcCtD
Cimetidine—Body temperature increased—Chlorambucil—testicular cancer	0.000489	0.00302	CcSEcCtD
Cimetidine—Gynaecomastia—Methotrexate—testicular cancer	0.000485	0.003	CcSEcCtD
Cimetidine—Constipation—Vinblastine—testicular cancer	0.000484	0.00299	CcSEcCtD
Cimetidine—HRH2—G alpha (s) signalling events—INSL3—testicular cancer	0.000484	0.0318	CbGpPWpGaD
Cimetidine—Atrioventricular block—Doxorubicin—testicular cancer	0.000484	0.00299	CcSEcCtD
Cimetidine—Confusional state—Bleomycin—testicular cancer	0.000482	0.00298	CcSEcCtD
Cimetidine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000482	0.0316	CbGpPWpGaD
Cimetidine—SLC22A3—seminal vesicle—testicular cancer	0.000479	0.0469	CbGeAlD
Cimetidine—Anaphylactic shock—Bleomycin—testicular cancer	0.000478	0.00296	CcSEcCtD
Cimetidine—Aplastic anaemia—Epirubicin—testicular cancer	0.000476	0.00295	CcSEcCtD
Cimetidine—Musculoskeletal pain—Doxorubicin—testicular cancer	0.000475	0.00294	CcSEcCtD
Cimetidine—Agranulocytosis—Etoposide—testicular cancer	0.000473	0.00292	CcSEcCtD
Cimetidine—Thrombocytopenia—Bleomycin—testicular cancer	0.000468	0.0029	CcSEcCtD
Cimetidine—Feeling abnormal—Vinblastine—testicular cancer	0.000467	0.00289	CcSEcCtD
Cimetidine—Myalgia—Dactinomycin—testicular cancer	0.000465	0.00288	CcSEcCtD
Cimetidine—ABCB11—testis—testicular cancer	0.000461	0.0451	CbGeAlD
Cimetidine—Agitation—Ifosfamide—testicular cancer	0.00046	0.00285	CcSEcCtD
Cimetidine—FMO3—testis—testicular cancer	0.000456	0.0445	CbGeAlD
Cimetidine—Hypersensitivity—Chlorambucil—testicular cancer	0.000455	0.00282	CcSEcCtD
Cimetidine—Malaise—Ifosfamide—testicular cancer	0.000452	0.00279	CcSEcCtD
Cimetidine—Leukopenia—Ifosfamide—testicular cancer	0.000448	0.00277	CcSEcCtD
Cimetidine—Asthenia—Chlorambucil—testicular cancer	0.000444	0.00274	CcSEcCtD
Cimetidine—Aplastic anaemia—Doxorubicin—testicular cancer	0.000441	0.00272	CcSEcCtD
Cimetidine—Alopecia—Cisplatin—testicular cancer	0.000438	0.00271	CcSEcCtD
Cimetidine—Hepatic failure—Methotrexate—testicular cancer	0.000438	0.00271	CcSEcCtD
Cimetidine—Thrombocytopenia—Dactinomycin—testicular cancer	0.000437	0.0027	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000436	0.00269	CcSEcCtD
Cimetidine—SLC47A1—gonad—testicular cancer	0.000434	0.0425	CbGeAlD
Cimetidine—Erythema multiforme—Etoposide—testicular cancer	0.00043	0.00266	CcSEcCtD
Cimetidine—Myalgia—Ifosfamide—testicular cancer	0.000427	0.00264	CcSEcCtD
Cimetidine—Arthralgia—Ifosfamide—testicular cancer	0.000427	0.00264	CcSEcCtD
Cimetidine—Flatulence—Cisplatin—testicular cancer	0.000426	0.00263	CcSEcCtD
Cimetidine—Diarrhoea—Chlorambucil—testicular cancer	0.000423	0.00261	CcSEcCtD
Cimetidine—Hypersensitivity—Vinblastine—testicular cancer	0.000417	0.00258	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Methotrexate—testicular cancer	0.000417	0.00258	CcSEcCtD
Cimetidine—SLC22A7—testis—testicular cancer	0.000416	0.0406	CbGeAlD
Cimetidine—Confusional state—Ifosfamide—testicular cancer	0.000412	0.00255	CcSEcCtD
Cimetidine—Hepatic failure—Epirubicin—testicular cancer	0.00041	0.00253	CcSEcCtD
Cimetidine—Anaphylactic shock—Ifosfamide—testicular cancer	0.000409	0.00253	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000407	0.00251	CcSEcCtD
Cimetidine—Asthenia—Vinblastine—testicular cancer	0.000406	0.00251	CcSEcCtD
Cimetidine—Alopecia—Etoposide—testicular cancer	0.000402	0.00248	CcSEcCtD
Cimetidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000402	0.0263	CbGpPWpGaD
Cimetidine—Thrombocytopenia—Ifosfamide—testicular cancer	0.0004	0.00247	CcSEcCtD
Cimetidine—Feeling abnormal—Bleomycin—testicular cancer	0.000394	0.00244	CcSEcCtD
Cimetidine—Vomiting—Chlorambucil—testicular cancer	0.000393	0.00243	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00039	0.00241	CcSEcCtD
Cimetidine—Malaise—Cisplatin—testicular cancer	0.00039	0.00241	CcSEcCtD
Cimetidine—Diarrhoea—Vinblastine—testicular cancer	0.000388	0.0024	CcSEcCtD
Cimetidine—Renal impairment—Epirubicin—testicular cancer	0.000387	0.00239	CcSEcCtD
Cimetidine—Leukopenia—Cisplatin—testicular cancer	0.000387	0.00239	CcSEcCtD
Cimetidine—SLC22A4—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000386	0.0253	CbGpPWpGaD
Cimetidine—Fatigue—Dactinomycin—testicular cancer	0.000385	0.00238	CcSEcCtD
Cimetidine—FMO1—lymph node—testicular cancer	0.000382	0.0374	CbGeAlD
Cimetidine—Hepatic failure—Doxorubicin—testicular cancer	0.000379	0.00234	CcSEcCtD
Cimetidine—Body temperature increased—Bleomycin—testicular cancer	0.000378	0.00234	CcSEcCtD
Cimetidine—Dizziness—Vinblastine—testicular cancer	0.000375	0.00232	CcSEcCtD
Cimetidine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000374	0.0246	CbGpPWpGaD
Cimetidine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000373	0.0023	CcSEcCtD
Cimetidine—Myalgia—Cisplatin—testicular cancer	0.000368	0.00227	CcSEcCtD
Cimetidine—Feeling abnormal—Dactinomycin—testicular cancer	0.000368	0.00227	CcSEcCtD
Cimetidine—Nausea—Chlorambucil—testicular cancer	0.000367	0.00227	CcSEcCtD
Cimetidine—Anxiety—Cisplatin—testicular cancer	0.000366	0.00227	CcSEcCtD
Cimetidine—Somnolence—Ifosfamide—testicular cancer	0.000364	0.00225	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.000361	0.00223	CcSEcCtD
Cimetidine—Vomiting—Vinblastine—testicular cancer	0.00036	0.00223	CcSEcCtD
Cimetidine—Renal impairment—Doxorubicin—testicular cancer	0.000358	0.00221	CcSEcCtD
Cimetidine—Malaise—Etoposide—testicular cancer	0.000357	0.00221	CcSEcCtD
Cimetidine—Headache—Vinblastine—testicular cancer	0.000355	0.00219	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000354	0.00219	CcSEcCtD
Cimetidine—Leukopenia—Etoposide—testicular cancer	0.000354	0.00219	CcSEcCtD
Cimetidine—SLC47A1—female gonad—testicular cancer	0.000353	0.0345	CbGeAlD
Cimetidine—Body temperature increased—Dactinomycin—testicular cancer	0.000353	0.00218	CcSEcCtD
Cimetidine—Fatigue—Ifosfamide—testicular cancer	0.000353	0.00218	CcSEcCtD
Cimetidine—Anaphylactic shock—Cisplatin—testicular cancer	0.000353	0.00218	CcSEcCtD
Cimetidine—Hypersensitivity—Bleomycin—testicular cancer	0.000353	0.00218	CcSEcCtD
Cimetidine—Constipation—Ifosfamide—testicular cancer	0.00035	0.00216	CcSEcCtD
Cimetidine—SLC22A5—seminal vesicle—testicular cancer	0.000349	0.0341	CbGeAlD
Cimetidine—SLC22A3—gonad—testicular cancer	0.000346	0.0339	CbGeAlD
Cimetidine—Thrombocytopenia—Cisplatin—testicular cancer	0.000345	0.00213	CcSEcCtD
Cimetidine—Blood creatinine increased—Epirubicin—testicular cancer	0.000345	0.00213	CcSEcCtD
Cimetidine—Tachycardia—Cisplatin—testicular cancer	0.000344	0.00213	CcSEcCtD
Cimetidine—SLC22A11—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000344	0.0226	CbGpPWpGaD
Cimetidine—Asthenia—Bleomycin—testicular cancer	0.000343	0.00212	CcSEcCtD
Cimetidine—Feeling abnormal—Ifosfamide—testicular cancer	0.000337	0.00208	CcSEcCtD
Cimetidine—Nausea—Vinblastine—testicular cancer	0.000336	0.00208	CcSEcCtD
Cimetidine—Pancreatitis—Methotrexate—testicular cancer	0.000334	0.00206	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000332	0.00205	CcSEcCtD
Cimetidine—FMO3—lymph node—testicular cancer	0.00033	0.0323	CbGeAlD
Cimetidine—Hypersensitivity—Dactinomycin—testicular cancer	0.000329	0.00203	CcSEcCtD
Cimetidine—Confusional state—Etoposide—testicular cancer	0.000326	0.00201	CcSEcCtD
Cimetidine—Body temperature increased—Ifosfamide—testicular cancer	0.000323	0.002	CcSEcCtD
Cimetidine—Pancytopenia—Methotrexate—testicular cancer	0.000323	0.002	CcSEcCtD
Cimetidine—Anaphylactic shock—Etoposide—testicular cancer	0.000323	0.002	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000321	0.00199	CcSEcCtD
Cimetidine—Asthenia—Dactinomycin—testicular cancer	0.00032	0.00198	CcSEcCtD
Cimetidine—Blood creatinine increased—Doxorubicin—testicular cancer	0.000319	0.00197	CcSEcCtD
Cimetidine—FMO1—Biological oxidations—HPGDS—testicular cancer	0.000319	0.0209	CbGpPWpGaD
Cimetidine—Neutropenia—Methotrexate—testicular cancer	0.000318	0.00197	CcSEcCtD
Cimetidine—Thrombocytopenia—Etoposide—testicular cancer	0.000316	0.00195	CcSEcCtD
Cimetidine—Tachycardia—Etoposide—testicular cancer	0.000315	0.00195	CcSEcCtD
Cimetidine—Erectile dysfunction—Methotrexate—testicular cancer	0.000313	0.00194	CcSEcCtD
Cimetidine—SLC47A1—testis—testicular cancer	0.000313	0.0306	CbGeAlD
Cimetidine—Pancreatitis—Epirubicin—testicular cancer	0.000312	0.00193	CcSEcCtD
Cimetidine—SLC22A7—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000312	0.0205	CbGpPWpGaD
Cimetidine—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000307	0.0019	CcSEcCtD
Cimetidine—Diarrhoea—Dactinomycin—testicular cancer	0.000305	0.00189	CcSEcCtD
Cimetidine—Pneumonia—Methotrexate—testicular cancer	0.000305	0.00189	CcSEcCtD
Cimetidine—Vomiting—Bleomycin—testicular cancer	0.000304	0.00188	CcSEcCtD
Cimetidine—Drowsiness—Methotrexate—testicular cancer	0.000303	0.00187	CcSEcCtD
Cimetidine—Pancytopenia—Epirubicin—testicular cancer	0.000302	0.00187	CcSEcCtD
Cimetidine—Rash—Bleomycin—testicular cancer	0.000302	0.00186	CcSEcCtD
Cimetidine—Dermatitis—Bleomycin—testicular cancer	0.000301	0.00186	CcSEcCtD
Cimetidine—Hypersensitivity—Ifosfamide—testicular cancer	0.000301	0.00186	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000301	0.00186	CcSEcCtD
Cimetidine—Renal failure—Methotrexate—testicular cancer	0.000298	0.00184	CcSEcCtD
Cimetidine—Neutropenia—Epirubicin—testicular cancer	0.000298	0.00184	CcSEcCtD
Cimetidine—HRH2—lymph node—testicular cancer	0.000294	0.0287	CbGeAlD
Cimetidine—Asthenia—Ifosfamide—testicular cancer	0.000293	0.00181	CcSEcCtD
Cimetidine—SLC22A3—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000291	0.0191	CbGpPWpGaD
Cimetidine—Feeling abnormal—Cisplatin—testicular cancer	0.000291	0.0018	CcSEcCtD
Cimetidine—SLC22A5—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00029	0.019	CbGpPWpGaD
Cimetidine—Pancreatitis—Doxorubicin—testicular cancer	0.000289	0.00179	CcSEcCtD
Cimetidine—Somnolence—Etoposide—testicular cancer	0.000287	0.00177	CcSEcCtD
Cimetidine—Pneumonia—Epirubicin—testicular cancer	0.000285	0.00176	CcSEcCtD
Cimetidine—Nausea—Bleomycin—testicular cancer	0.000284	0.00176	CcSEcCtD
Cimetidine—CYP2E1—seminal vesicle—testicular cancer	0.000284	0.0278	CbGeAlD
Cimetidine—Drowsiness—Epirubicin—testicular cancer	0.000284	0.00175	CcSEcCtD
Cimetidine—Vomiting—Dactinomycin—testicular cancer	0.000284	0.00175	CcSEcCtD
Cimetidine—Agranulocytosis—Methotrexate—testicular cancer	0.000283	0.00175	CcSEcCtD
Cimetidine—SLC47A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000283	0.0186	CbGpPWpGaD
Cimetidine—SLC22A3—female gonad—testicular cancer	0.000282	0.0275	CbGeAlD
Cimetidine—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000281	0.00174	CcSEcCtD
Cimetidine—Rash—Dactinomycin—testicular cancer	0.000281	0.00174	CcSEcCtD
Cimetidine—Diarrhoea—Ifosfamide—testicular cancer	0.00028	0.00173	CcSEcCtD
Cimetidine—Pancytopenia—Doxorubicin—testicular cancer	0.00028	0.00173	CcSEcCtD
Cimetidine—Renal failure—Epirubicin—testicular cancer	0.000279	0.00172	CcSEcCtD
Cimetidine—Body temperature increased—Cisplatin—testicular cancer	0.000279	0.00172	CcSEcCtD
Cimetidine—Fatigue—Etoposide—testicular cancer	0.000278	0.00172	CcSEcCtD
Cimetidine—Constipation—Etoposide—testicular cancer	0.000276	0.00171	CcSEcCtD
Cimetidine—Neutropenia—Doxorubicin—testicular cancer	0.000275	0.0017	CcSEcCtD
Cimetidine—Hepatitis—Methotrexate—testicular cancer	0.000272	0.00168	CcSEcCtD
Cimetidine—Dizziness—Ifosfamide—testicular cancer	0.00027	0.00167	CcSEcCtD
Cimetidine—Feeling abnormal—Etoposide—testicular cancer	0.000266	0.00165	CcSEcCtD
Cimetidine—Nausea—Dactinomycin—testicular cancer	0.000265	0.00164	CcSEcCtD
Cimetidine—Agranulocytosis—Epirubicin—testicular cancer	0.000265	0.00164	CcSEcCtD
Cimetidine—Pneumonia—Doxorubicin—testicular cancer	0.000264	0.00163	CcSEcCtD
Cimetidine—Drowsiness—Doxorubicin—testicular cancer	0.000263	0.00162	CcSEcCtD
Cimetidine—SLC22A8—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000262	0.0172	CbGpPWpGaD
Cimetidine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00026	0.00161	CcSEcCtD
Cimetidine—Vomiting—Ifosfamide—testicular cancer	0.00026	0.00161	CcSEcCtD
Cimetidine—Hypersensitivity—Cisplatin—testicular cancer	0.00026	0.00161	CcSEcCtD
Cimetidine—Bradycardia—Epirubicin—testicular cancer	0.000259	0.0016	CcSEcCtD
Cimetidine—Renal failure—Doxorubicin—testicular cancer	0.000258	0.0016	CcSEcCtD
Cimetidine—Rash—Ifosfamide—testicular cancer	0.000258	0.00159	CcSEcCtD
Cimetidine—Dermatitis—Ifosfamide—testicular cancer	0.000258	0.00159	CcSEcCtD
Cimetidine—Erythema multiforme—Methotrexate—testicular cancer	0.000257	0.00159	CcSEcCtD
Cimetidine—Body temperature increased—Etoposide—testicular cancer	0.000255	0.00158	CcSEcCtD
Cimetidine—Hepatitis—Epirubicin—testicular cancer	0.000255	0.00158	CcSEcCtD
Cimetidine—Asthenia—Cisplatin—testicular cancer	0.000253	0.00156	CcSEcCtD
Cimetidine—SLC22A3—testis—testicular cancer	0.00025	0.0244	CbGeAlD
Cimetidine—Agranulocytosis—Doxorubicin—testicular cancer	0.000245	0.00152	CcSEcCtD
Cimetidine—Nausea—Ifosfamide—testicular cancer	0.000243	0.0015	CcSEcCtD
Cimetidine—Diarrhoea—Cisplatin—testicular cancer	0.000241	0.00149	CcSEcCtD
Cimetidine—Erythema multiforme—Epirubicin—testicular cancer	0.000241	0.00149	CcSEcCtD
Cimetidine—Alopecia—Methotrexate—testicular cancer	0.000241	0.00149	CcSEcCtD
Cimetidine—Bradycardia—Doxorubicin—testicular cancer	0.00024	0.00148	CcSEcCtD
Cimetidine—Hypersensitivity—Etoposide—testicular cancer	0.000238	0.00147	CcSEcCtD
Cimetidine—Hepatitis—Doxorubicin—testicular cancer	0.000236	0.00146	CcSEcCtD
Cimetidine—Asthenia—Etoposide—testicular cancer	0.000232	0.00143	CcSEcCtD
Cimetidine—HRH2—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000231	0.0151	CbGpPWpGaD
Cimetidine—FMO3—Biological oxidations—HPGDS—testicular cancer	0.000228	0.015	CbGpPWpGaD
Cimetidine—SLC47A1—lymph node—testicular cancer	0.000227	0.0222	CbGeAlD
Cimetidine—Alopecia—Epirubicin—testicular cancer	0.000225	0.00139	CcSEcCtD
Cimetidine—Vomiting—Cisplatin—testicular cancer	0.000224	0.00139	CcSEcCtD
Cimetidine—Erythema multiforme—Doxorubicin—testicular cancer	0.000223	0.00138	CcSEcCtD
Cimetidine—Rash—Cisplatin—testicular cancer	0.000222	0.00137	CcSEcCtD
Cimetidine—Dermatitis—Cisplatin—testicular cancer	0.000222	0.00137	CcSEcCtD
Cimetidine—Diarrhoea—Etoposide—testicular cancer	0.000221	0.00137	CcSEcCtD
Cimetidine—SLC22A6—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000219	0.0144	CbGpPWpGaD
Cimetidine—Flatulence—Epirubicin—testicular cancer	0.000219	0.00135	CcSEcCtD
Cimetidine—Malaise—Methotrexate—testicular cancer	0.000214	0.00132	CcSEcCtD
Cimetidine—Dizziness—Etoposide—testicular cancer	0.000214	0.00132	CcSEcCtD
Cimetidine—Leukopenia—Methotrexate—testicular cancer	0.000212	0.00131	CcSEcCtD
Cimetidine—Nausea—Cisplatin—testicular cancer	0.000209	0.00129	CcSEcCtD
Cimetidine—Alopecia—Doxorubicin—testicular cancer	0.000208	0.00129	CcSEcCtD
Cimetidine—Vomiting—Etoposide—testicular cancer	0.000205	0.00127	CcSEcCtD
Cimetidine—SLC22A5—female gonad—testicular cancer	0.000205	0.02	CbGeAlD
Cimetidine—Agitation—Epirubicin—testicular cancer	0.000204	0.00126	CcSEcCtD
Cimetidine—Rash—Etoposide—testicular cancer	0.000204	0.00126	CcSEcCtD
Cimetidine—Dermatitis—Etoposide—testicular cancer	0.000203	0.00126	CcSEcCtD
Cimetidine—Headache—Etoposide—testicular cancer	0.000202	0.00125	CcSEcCtD
Cimetidine—Flatulence—Doxorubicin—testicular cancer	0.000202	0.00125	CcSEcCtD
Cimetidine—Myalgia—Methotrexate—testicular cancer	0.000202	0.00125	CcSEcCtD
Cimetidine—Arthralgia—Methotrexate—testicular cancer	0.000202	0.00125	CcSEcCtD
Cimetidine—Malaise—Epirubicin—testicular cancer	0.0002	0.00124	CcSEcCtD
Cimetidine—SLC22A4—lymph node—testicular cancer	0.000199	0.0194	CbGeAlD
Cimetidine—Leukopenia—Epirubicin—testicular cancer	0.000199	0.00123	CcSEcCtD
Cimetidine—SLC22A4—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000196	0.0129	CbGpPWpGaD
Cimetidine—Confusional state—Methotrexate—testicular cancer	0.000195	0.00121	CcSEcCtD
Cimetidine—Anaphylactic shock—Methotrexate—testicular cancer	0.000193	0.0012	CcSEcCtD
Cimetidine—Nausea—Etoposide—testicular cancer	0.000192	0.00119	CcSEcCtD
Cimetidine—Thrombocytopenia—Methotrexate—testicular cancer	0.000189	0.00117	CcSEcCtD
Cimetidine—Arthralgia—Epirubicin—testicular cancer	0.000189	0.00117	CcSEcCtD
Cimetidine—Myalgia—Epirubicin—testicular cancer	0.000189	0.00117	CcSEcCtD
Cimetidine—Agitation—Doxorubicin—testicular cancer	0.000189	0.00117	CcSEcCtD
Cimetidine—Anxiety—Epirubicin—testicular cancer	0.000188	0.00116	CcSEcCtD
Cimetidine—CYP11B1—Biological oxidations—HPGDS—testicular cancer	0.000188	0.0123	CbGpPWpGaD
Cimetidine—Malaise—Doxorubicin—testicular cancer	0.000185	0.00114	CcSEcCtD
Cimetidine—Leukopenia—Doxorubicin—testicular cancer	0.000184	0.00114	CcSEcCtD
Cimetidine—Confusional state—Epirubicin—testicular cancer	0.000183	0.00113	CcSEcCtD
Cimetidine—SLC22A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000183	0.012	CbGpPWpGaD
Cimetidine—SLC22A5—testis—testicular cancer	0.000182	0.0177	CbGeAlD
Cimetidine—Anaphylactic shock—Epirubicin—testicular cancer	0.000181	0.00112	CcSEcCtD
Cimetidine—SLC22A3—lymph node—testicular cancer	0.000181	0.0177	CbGeAlD
Cimetidine—CYP3A5—female gonad—testicular cancer	0.000179	0.0175	CbGeAlD
Cimetidine—Thrombocytopenia—Epirubicin—testicular cancer	0.000177	0.0011	CcSEcCtD
Cimetidine—Tachycardia—Epirubicin—testicular cancer	0.000177	0.00109	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000176	0.00109	CcSEcCtD
Cimetidine—HRH2—GPCR ligand binding—INSL3—testicular cancer	0.000176	0.0115	CbGpPWpGaD
Cimetidine—CYP2C8—testis—testicular cancer	0.000176	0.0172	CbGeAlD
Cimetidine—SLC22A11—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000175	0.0115	CbGpPWpGaD
Cimetidine—Arthralgia—Doxorubicin—testicular cancer	0.000175	0.00108	CcSEcCtD
Cimetidine—Myalgia—Doxorubicin—testicular cancer	0.000175	0.00108	CcSEcCtD
Cimetidine—Anxiety—Doxorubicin—testicular cancer	0.000174	0.00108	CcSEcCtD
Cimetidine—ABCB1—embryo—testicular cancer	0.000172	0.0168	CbGeAlD
Cimetidine—Somnolence—Methotrexate—testicular cancer	0.000172	0.00106	CcSEcCtD
Cimetidine—SLC22A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00017	0.0112	CbGpPWpGaD
Cimetidine—Confusional state—Doxorubicin—testicular cancer	0.000169	0.00104	CcSEcCtD
Cimetidine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000168	0.00104	CcSEcCtD
Cimetidine—Fatigue—Methotrexate—testicular cancer	0.000167	0.00103	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000165	0.00102	CcSEcCtD
Cimetidine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000164	0.00101	CcSEcCtD
Cimetidine—Tachycardia—Doxorubicin—testicular cancer	0.000163	0.00101	CcSEcCtD
Cimetidine—ABCB1—seminal vesicle—testicular cancer	0.000162	0.0158	CbGeAlD
Cimetidine—Somnolence—Epirubicin—testicular cancer	0.000161	0.000995	CcSEcCtD
Cimetidine—Feeling abnormal—Methotrexate—testicular cancer	0.000159	0.000985	CcSEcCtD
Cimetidine—SLC22A7—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000159	0.0104	CbGpPWpGaD
Cimetidine—Fatigue—Epirubicin—testicular cancer	0.000156	0.000965	CcSEcCtD
Cimetidine—CYP2C8—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000155	0.0102	CbGpPWpGaD
Cimetidine—Constipation—Epirubicin—testicular cancer	0.000155	0.000957	CcSEcCtD
Cimetidine—Body temperature increased—Methotrexate—testicular cancer	0.000153	0.000945	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000153	0.000943	CcSEcCtD
Cimetidine—Feeling abnormal—Epirubicin—testicular cancer	0.000149	0.000922	CcSEcCtD
Cimetidine—Somnolence—Doxorubicin—testicular cancer	0.000149	0.000921	CcSEcCtD
Cimetidine—CYP2E1—testis—testicular cancer	0.000148	0.0145	CbGeAlD
Cimetidine—SLC22A3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000148	0.0097	CbGpPWpGaD
Cimetidine—SLC22A5—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000147	0.00967	CbGpPWpGaD
Cimetidine—Fatigue—Doxorubicin—testicular cancer	0.000144	0.000893	CcSEcCtD
Cimetidine—Constipation—Doxorubicin—testicular cancer	0.000143	0.000885	CcSEcCtD
Cimetidine—Body temperature increased—Epirubicin—testicular cancer	0.000143	0.000885	CcSEcCtD
Cimetidine—Hypersensitivity—Methotrexate—testicular cancer	0.000143	0.000881	CcSEcCtD
Cimetidine—Asthenia—Methotrexate—testicular cancer	0.000139	0.000858	CcSEcCtD
Cimetidine—CYP2C19—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000139	0.00909	CbGpPWpGaD
Cimetidine—Feeling abnormal—Doxorubicin—testicular cancer	0.000138	0.000853	CcSEcCtD
Cimetidine—Hypersensitivity—Epirubicin—testicular cancer	0.000133	0.000825	CcSEcCtD
Cimetidine—SLC22A8—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000133	0.00874	CbGpPWpGaD
Cimetidine—Body temperature increased—Doxorubicin—testicular cancer	0.000132	0.000819	CcSEcCtD
Cimetidine—Diarrhoea—Methotrexate—testicular cancer	0.000132	0.000818	CcSEcCtD
Cimetidine—CYP2D6—female gonad—testicular cancer	0.000132	0.0129	CbGeAlD
Cimetidine—SLC22A5—lymph node—testicular cancer	0.000132	0.0129	CbGeAlD
Cimetidine—Asthenia—Epirubicin—testicular cancer	0.00013	0.000803	CcSEcCtD
Cimetidine—Dizziness—Methotrexate—testicular cancer	0.000128	0.000791	CcSEcCtD
Cimetidine—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000126	0.00829	CbGpPWpGaD
Cimetidine—Diarrhoea—Epirubicin—testicular cancer	0.000124	0.000766	CcSEcCtD
Cimetidine—Hypersensitivity—Doxorubicin—testicular cancer	0.000123	0.000763	CcSEcCtD
Cimetidine—Vomiting—Methotrexate—testicular cancer	0.000123	0.00076	CcSEcCtD
Cimetidine—Rash—Methotrexate—testicular cancer	0.000122	0.000754	CcSEcCtD
Cimetidine—Dermatitis—Methotrexate—testicular cancer	0.000122	0.000753	CcSEcCtD
Cimetidine—Headache—Methotrexate—testicular cancer	0.000121	0.000749	CcSEcCtD
Cimetidine—Asthenia—Doxorubicin—testicular cancer	0.00012	0.000743	CcSEcCtD
Cimetidine—Dizziness—Epirubicin—testicular cancer	0.00012	0.00074	CcSEcCtD
Cimetidine—CYP2D6—testis—testicular cancer	0.000117	0.0115	CbGeAlD
Cimetidine—ABCB1—gonad—testicular cancer	0.000117	0.0114	CbGeAlD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000115	0.00757	CbGpPWpGaD
Cimetidine—Vomiting—Epirubicin—testicular cancer	0.000115	0.000712	CcSEcCtD
Cimetidine—Nausea—Methotrexate—testicular cancer	0.000115	0.00071	CcSEcCtD
Cimetidine—Diarrhoea—Doxorubicin—testicular cancer	0.000115	0.000708	CcSEcCtD
Cimetidine—Rash—Epirubicin—testicular cancer	0.000114	0.000706	CcSEcCtD
Cimetidine—Dermatitis—Epirubicin—testicular cancer	0.000114	0.000705	CcSEcCtD
Cimetidine—Headache—Epirubicin—testicular cancer	0.000113	0.000701	CcSEcCtD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000111	0.0073	CbGpPWpGaD
Cimetidine—Dizziness—Doxorubicin—testicular cancer	0.000111	0.000685	CcSEcCtD
Cimetidine—CYP1A2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000108	0.00709	CbGpPWpGaD
Cimetidine—Nausea—Epirubicin—testicular cancer	0.000108	0.000665	CcSEcCtD
Cimetidine—Vomiting—Doxorubicin—testicular cancer	0.000107	0.000658	CcSEcCtD
Cimetidine—Rash—Doxorubicin—testicular cancer	0.000106	0.000653	CcSEcCtD
Cimetidine—Dermatitis—Doxorubicin—testicular cancer	0.000106	0.000652	CcSEcCtD
Cimetidine—Headache—Doxorubicin—testicular cancer	0.000105	0.000649	CcSEcCtD
Cimetidine—Nausea—Doxorubicin—testicular cancer	9.95e-05	0.000615	CcSEcCtD
Cimetidine—HRH2—GPCR downstream signaling—INSL3—testicular cancer	9.93e-05	0.00652	CbGpPWpGaD
Cimetidine—ABCB1—female gonad—testicular cancer	9.5e-05	0.00929	CbGeAlD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	9.27e-05	0.00608	CbGpPWpGaD
Cimetidine—CYP3A7—Biological oxidations—HPGDS—testicular cancer	9.23e-05	0.00606	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—INSL3—testicular cancer	9.02e-05	0.00592	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	8.64e-05	0.00567	CbGpPWpGaD
Cimetidine—ABCB1—testis—testicular cancer	8.43e-05	0.00824	CbGeAlD
Cimetidine—CYP11B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	7.21e-05	0.00473	CbGpPWpGaD
Cimetidine—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	6.87e-05	0.00451	CbGpPWpGaD
Cimetidine—CYP2E1—Biological oxidations—HPGDS—testicular cancer	6.69e-05	0.00439	CbGpPWpGaD
Cimetidine—CYP3A5—Biological oxidations—HPGDS—testicular cancer	6.67e-05	0.00438	CbGpPWpGaD
Cimetidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	6.31e-05	0.00414	CbGpPWpGaD
Cimetidine—ABCB1—lymph node—testicular cancer	6.11e-05	0.00597	CbGeAlD
Cimetidine—CYP2C8—Biological oxidations—HPGDS—testicular cancer	5.78e-05	0.00379	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—HPGDS—testicular cancer	5.46e-05	0.00358	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.41e-05	0.00355	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—INSL3—testicular cancer	5.33e-05	0.0035	CbGpPWpGaD
Cimetidine—CYP2C19—Biological oxidations—HPGDS—testicular cancer	5.16e-05	0.00338	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	5.07e-05	0.00332	CbGpPWpGaD
Cimetidine—CYP2D6—Biological oxidations—HPGDS—testicular cancer	4.75e-05	0.00311	CbGpPWpGaD
Cimetidine—CYP2C9—Biological oxidations—HPGDS—testicular cancer	4.71e-05	0.00309	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	4.63e-05	0.00304	CbGpPWpGaD
Cimetidine—CYP1A2—Biological oxidations—HPGDS—testicular cancer	4.02e-05	0.00264	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—STK11—testicular cancer	3.96e-05	0.0026	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—HPGDS—testicular cancer	3.9e-05	0.00256	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	3.37e-05	0.00221	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—HPGDS—testicular cancer	3.21e-05	0.0021	CbGpPWpGaD
Cimetidine—CYP3A4—Biological oxidations—HPGDS—testicular cancer	3.1e-05	0.00204	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—STK11—testicular cancer	2.83e-05	0.00186	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—HPGDS—testicular cancer	2.51e-05	0.00165	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—HPGDS—testicular cancer	2.41e-05	0.00158	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—STK11—testicular cancer	2.33e-05	0.00153	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.22e-05	0.00146	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.98e-05	0.0013	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—STK11—testicular cancer	1.83e-05	0.0012	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.81e-05	0.00119	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—STK11—testicular cancer	1.75e-05	0.00115	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—H2AFZ—testicular cancer	1.71e-05	0.00112	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—STK11—testicular cancer	1.7e-05	0.00111	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—HPGDS—testicular cancer	1.58e-05	0.00104	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—HPGDS—testicular cancer	1.58e-05	0.00103	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—KITLG—testicular cancer	1.57e-05	0.00103	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.54e-05	0.00101	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—HPGDS—testicular cancer	1.47e-05	0.000964	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—FGFR3—testicular cancer	1.17e-05	0.000765	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—STK11—testicular cancer	1.15e-05	0.000753	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—STK11—testicular cancer	1.15e-05	0.000751	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—HPGDS—testicular cancer	1.14e-05	0.00075	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—HPGDS—testicular cancer	1.14e-05	0.000749	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—KIT—testicular cancer	1.07e-05	0.000702	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—STK11—testicular cancer	1.07e-05	0.0007	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—HPGDS—testicular cancer	9.89e-06	0.000648	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—HPGDS—testicular cancer	8.82e-06	0.000579	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—HPGDS—testicular cancer	8.61e-06	0.000565	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—STK11—testicular cancer	8.31e-06	0.000545	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—STK11—testicular cancer	8.29e-06	0.000544	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—HPGDS—testicular cancer	8.12e-06	0.000532	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—HPGDS—testicular cancer	8.05e-06	0.000528	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—STK11—testicular cancer	7.18e-06	0.000471	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—HPGDS—testicular cancer	6.88e-06	0.000451	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—STK11—testicular cancer	6.41e-06	0.000421	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—STK11—testicular cancer	6.26e-06	0.00041	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—STK11—testicular cancer	5.9e-06	0.000387	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—STK11—testicular cancer	5.85e-06	0.000383	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—HPGDS—testicular cancer	5.31e-06	0.000348	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—STK11—testicular cancer	5e-06	0.000328	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—STK11—testicular cancer	3.86e-06	0.000253	CbGpPWpGaD
